Finasteride treatment for one year in 35 hirsute patients


Bayram F., Muderris I., Sahin Y., Kelestimur F.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.107, no.3, pp.195-197, 1999 (SCI-Expanded) identifier identifier identifier

Abstract

This study was performed to confirm the favourable therapeutic effects of finasteride in hirsute women as described by previous publications of different research groups. Our study was a non-randomized, prospective clinical trial. Thirty five patients with hirsutism were included in the study. The patients received 5 mg finasteride orally once per day over a period of 12 months. Hirsutism score, FSH, LH, E-2, total T, free T, androstenedione (A), DHEAS, 17-hydroxyprogesterone (17-OHP) and sex hormone-binding globulin (SHBG) levels were determined in all the patients before treatment and every 6 months during treatment.